JAMA Neurology
Original Investigation
February 6, 2023
Stephanie Meier, MSc; Eline A.J. Willemse, PhD; Sabine Schaedelin, MSc; Johanna Oechtering, MD; Johannes Lorscheider, MD; Lester Melie-Garcia, PhD; Alessandro Cagol, MD; Muhamed Barakovic, PhD; Riccardo Galbusera, MD; Suvitha Subramaniam, MSc; Christian Barro, MD; Ahmed Abdelhak, MD; Simon Thebault, MD; Lutz Achtnichts, MD; Patrice Lalive, MD; Stefanie Müller, MD; Caroline Pot, MD; Anke Salmen, MD; Giulio Disanto, MD; Chiara Zecca, MD; Marcus D’Souza, MD; Annette Orleth, PhD; Michael Khalil, MD; Arabella Buchmann, MSc; Renaud Du Pasquier, MD; Özgür Yaldizli, MD; Tobias Derfuss, MD; Klaus Berger, MD; Marco Hermesdorf, MD; Heinz Wiendl, MD; Fredrik Piehl, MD; Marco Battaglini, PhD; Urs Fischer, MD; Ludwig Kappos, MD; Claudio Gobbi, MD; Cristina Granziera, MD; Claire Bridel, MD; David Leppert, MD; Aleksandra Maleska Maceski, MSc; Pascal Benkert, PhD; Jens Kuhle, MD
online first
JAMA Neurol. 2023; doi: 10.1001/jamaneurol.2022.5250
This cohort study investigates if concentrations of serum glial fibrillary acidic protein and neurofilament light chain are associated with and prognostic for disease progression in patients with multiple sclerosis.
JAMA Neurology
Viewpoint
February 6, 2023
Clare McCormack, PhD; Bridget L. Callaghan, PhD; Jodi L. Pawluski, PhD, HDR
online first
JAMA Neurol. 2023; doi: 10.1001/jamaneurol.2022.5180
This Viewpoint discusses the concept of “mommy brain” and why it needs to change.
JAMA Neurology
Original Investigation
February 6, 2023
Niklas Mattsson-Carlgren, MD, PhD; Gemma Salvadó, PhD; Nicholas J. Ashton, PhD; Pontus Tideman, MSc; Erik Stomrud, MD, PhD; Henrik Zetterberg, MD, PhD; Rik Ossenkoppele, PhD; Tobey J. Betthauser, PhD; Karly Alex Cody, BS; Erin M. Jonaitis, MS, PhD; Rebecca Langhough, PhD; Sebastian Palmqvist, MD, PhD; Kaj Blennow, MD, PhD; Shorena Janelidze, PhD; Sterling C. Johnson, PhD; Oskar Hansson, MD, PhD
open access
online first
JAMA Neurol. 2023; doi: 10.1001/jamaneurol.2022.5272
This prognostic study uses data from the Swedish BioFINDER-1 and Wisconsin Registry for Alzheimer Prevention longitudinal cohort studies to evaluate whether combinations of different plasma biomarkers can predict cognitive decline in cognitively unimpaired individuals with β-amyloid positivity.
JAMA Neurology
Images in Neurology
February 6, 2023
Omar Baqal, MBBS; Aimen Vanood, MD; Ehab Harahsheh, MBBS
is active quiz
online first
JAMA Neurol. 2023; doi: 10.1001/jamaneurol.2022.5197
This case report describes a patient with status epilepticus and neuroimaging features of fleeting T2 fluid-attenuated inversion recovery hyperintense lesions on magnetic resonance imaging.
JAMA Network Open
February 6, 2023